E2A Antibodies

Santa Cruz Biotechnology provides a broad selection of E2A monoclonal antibodies for research focused on understanding E2A protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). E2A is a transcription factor that plays a critical role in the regulation of gene expression during B and T cell development. E2A functions are essential for the differentiation of lymphocytes and have been implicated in various immune responses and hematological malignancies. Understanding E2A activity is vital for elucidating mechanisms of immune regulation and potential therapeutic targets in cancer. Researchers can utilize E2A monoclonal antibodies to investigate protein expression patterns across different cell types and tissues. Advanced research techniques incorporating E2A monoclonal antibodies enable detailed analysis of protein-protein interactions and cellular localization. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of immune system development and disease mechanisms.